AI Generated
Oct 27, 2026, 03:45
Melissa Barlow: Cancer Risk After Platelet Count and CRP Testing
Melissa Barlow, Postdoctoral Researcher at University of Exeter Medical School, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in BMJ Journals, adding:
“New paper published today in BMJ Open ’Cancer incidence following platelet count and C-reactive protein testing across ethnic groups in English primary care: a cohort study of 5 million patients’.”
Title: Cancer incidence following platelet count and C-reactive protein testing across ethnic groups in English primary care: a cohort study of 5 million patients
Authors: Melissa Barlow, Liz Down, Luke T A Mounce, Samuel W D Merriel, Jessica Watson, Tanimola Martins, Sarah E R Bailey
Stay updated with Hemostasis Today.
-
Oct 27, 2026, 03:38Nnadozie Gabriel C.: What Everyone Needs to Know about BE FAST
-
Oct 27, 2026, 03:30Pouya Tahsili-Fahadan: Evolving Boundaries in Acute Stroke Care – Key Takeaways from WSC 2026
-
Oct 27, 2026, 03:27Kristin N.: Could Elritercept Change How We Manage Anemia in Lower-Risk MDS?
-
Oct 27, 2026, 03:22David J McCormack: Hybrid LAA Closure Prevents Recurrent Stroke Without Blood Thinners
-
Oct 26, 2026, 20:09Augustina Isioma Ikusemoro: Advancing PBM Through Evidence-Based, Patient-Centred Transfusion Care
-
Oct 26, 2026, 20:03David McIntosh: Outdated Plasma Collection Methods and the Global Shortage of Plasma-Derived Medicines
-
Oct 26, 2026, 20:00José Antonio García Erce: Recognizing Professor Marcela Contreras’ Contributions to Spanish Hematology
-
Oct 26, 2026, 19:47Ahmed Boukaraa: Transfusion Safety – Have You Checked Calcium Levels before Transfusing?
-
Oct 26, 2026, 19:43Mohd J. Maaita: The Classic Golf Ball Appearance in Hemoglobin H Disease